Comparison between local abdominal and transcutaneous tail vein photobiomodulation in experimental rat model of ulcerative colitis

Lasers Med Sci. 2023 Oct 28;38(1):247. doi: 10.1007/s10103-023-03910-2.

Abstract

Ulcerative colitis (UC) is a chronic autoimmune disease that impacts the quality of life, but current pharmacological treatments are limited. Photobiomodulation (PBM) is a light-based treatment that can be applied either locally or systemically. Here, we compare the effects of local and vascular PBM (VPBM) in an experimental rat model of UC. Male Wistar rats were induced with UC by rectal instillation of acetic acid and treated with either local abdominal PBM or VPBM to the tail vein using a 660-nm LED. The findings indicated that local PBM but not VPBM reduced intestinal histological scores. Both local and VPBM increased mucus production, decreased mast cell degranulation, and modulated TNF-α and IL-1 β levels in the intestines. Local PBM also affected the expression of the mRNAs for IL-6, TNF-α, and IFN-γ. In conclusion, we suggest that local PBM appears to be more promising than VPBM for treating UC. However, further research is needed to fully understand the mechanisms and to optimize the parameters of PBM for UC treatment.

Keywords: Cytokines; Local abdominal photobiomodulation; Rat model; Transcutaneous vascular photobiomodulation; Ulcerative colitis.

MeSH terms

  • Animals
  • Colitis, Ulcerative* / drug therapy
  • Colitis, Ulcerative* / radiotherapy
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology
  • Male
  • Quality of Life
  • Rats
  • Rats, Wistar
  • Tail / pathology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Tumor Necrosis Factor-alpha

Grants and funding